Average Co-Inventor Count = 5.80
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glenmark Specialty S.a. (14 from 24 patents)
2. Glenmark Pharmaceuticals Limited (1 from 30 patents)
15 patents:
1. 12303635 - Dispensing device and pharmaceutical composition for the treatment of rhinitis
2. 11679210 - Dispensing device and pharmaceutical composition for the treatment of rhinitis
3. 10765686 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
4. 10653683 - Tiotropium inhalation solution for nebulization
5. 10632108 - Tiotropium inhalation solution for nebulization
6. 10632109 - Tiotropium inhalation solution for nebulization
7. 10561672 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
8. 10517880 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
9. 10376526 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
10. 9987260 - Tiotropium inhalation solution for nebulization
11. 9937189 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
12. 9757365 - Tiotropium inhalation solution for nebulization
13. 9750754 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
14. 9370483 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
15. 9078923 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine